Trial Profile
Phase I trial of Demogastrin (99mTc-Demogastrin 2) in patients with Medullary Thyroid Carcinoma (MTC)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Apr 2016
Price :
$35
*
At a glance
- Drugs Tc 99m-demogastrin 2 (Primary)
- Indications Thyroid cancer
- Focus Adverse reactions
- Sponsors Biomedica Life Sciences
- 01 Apr 2016 New trial record